Journal of Clinical Densitometry
Volume 12, Issue 4 , Pages 417-427 , October 2009

25-Hydroxyvitamin D Measurement, 2009: A Review for Clinicians

  • Neil Binkley

      Affiliations

    • Osteoporosis Clinical Center and Research Program, University of Wisconsin-Madison, Madison, WI, USA
    • Corresponding Author InformationAddress correspondence to: Neil Binkley, MD, University of Wisconsin Osteoporosis Research Program, 2870 University Avenue, Suite 100, Madison, WI 53705.
    • ,
  • Diane Krueger

      Affiliations

    • Osteoporosis Clinical Center and Research Program, University of Wisconsin-Madison, Madison, WI, USA
    • ,
  • Gary Lensmeyer

      Affiliations

    • Department of Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA

Received 7 March 2009 ,Revised 5 June 2009 ,Accepted 5 June 2009.

References 

  1. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61(3 Suppl):638S–645S
  2. Holick MF. The photobiology of vitamin D and its consequences for humans. Ann N Y Acad Sci. 1985;453:1–13
  3. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–777
  4. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. Can Med Assoc J. 2002;166:1517–1524
  5. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76:187–192
  6. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev. 2003;61:107–113
  7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  8. Binkley N. Does low vitamin D status contribute to “age-related” morbidity?. J Bone Miner Res. 2007;22:V55–V58
  9. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J. 1988;2:224–236
  10. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine . DRI Dietary Reference Intakes for calcium phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press; 1997;
  11. Hollis BW, Horst RL. The assessment of circulating 25(OH)D and 1, 25 (OH)2D: where we are and where we are going. J Steroid Biochem Mol Biol. 2007;103:473–476
  12. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387–5391
  13. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84:694–697
  14. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93:677–681
  15. Glendenning P, Seymour H, Gillett MJ, et al. Ergocalciferol is not bioequivalent to cholecalciferol in vitamin D insufficient hip fracture cases. J Bone Miner Res. 2008;23(Suppl):S81
  16. Anonymous Vitamin D deficiency: informationfor cancer patients. 2008 (Accessed: October 24, 2008, Available at: www.boneandcancerfoundation.org).
  17. Holick MF. Too little vitamin D in premenopausal women: why should we care?. Am J Clin Nutr. 2002;76:3–4
  18. Giovannucci E. Can vitamin D reduce total mortality?. Arch Intern Med. 2007;167:1709–1710
  19. Anonymous. 2007 Annual report of the boards of trustees of the federal hospital insurance and federal supplementary medical insurance trust funds. (Accessed: October 23, 2008, Available at: www.cms.hhs.gov/reportstrustfunds/downloads/tr2007.pdf).
  20. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr. 2006;136:1123–1125
  21. Binkley N, Gemar D, Woods A, et al. Effect of vitamin D2 or vitamin D3 supplementation on serum 25OHD. J Bone Miner Res. 2008;23(Suppl 1):S350
  22. MacLaughlin JA, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536–1538
  23. Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr. 2004;80(6 Suppl):1735S–1739S
  24. Matsuoka LY, Wortsman J, Haddad JG, et al. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol. 1991;127:536–538
  25. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971;33:992–995
  26. Belsey R, DeLuca H, Potts J. Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endocrinol Metab. 1971;33:554–557
  27. Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem. 1985;31:1815–1819
  28. Gamma B 25-hydroxy vitamin D RIA [package insert]. Boldon, UK: IDA Ltd; 2005;
  29. Leino A, Turpeinen U, Koskinen P. Automated measurement of 25-OH vitamin D3 on the Roche modular E170 analyzer. Clin Chem. 2008;54:1–4
  30. Caldwell RD, Porteous CE, Trafford DJ, Makin HL. Gas chromatography-mass spectrometry and the measurement of vitamin D metabolites in human serum or plasma. Steroids. 1987;49:155–196
  31. Seamark DA, Trafford DJ, Makin HL. The estimation of vitamin D and some metabolites in human plasma by mass fragmentography. Clin Chim Acta. 1980;106:51–62
  32. Eisman JA, Shepard RM, DeLuca HF. Determination of 25-hydroxyvitamin D2 and of 25-hydroxyvitamin D3 in plasma using high-pressure liquid chromatography. Anal Biochem. 1977;90:298–305
  33. Turpeinen U, Hohenthal U, Stenman UH. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem. 2003;49:1521–1524
  34. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. Measurement of 25-hydroxyvitamin D revisited: reply to letter. Clin Chem. 2006;52:2305–2306
  35. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for the simultaneous measurement of the 25-hydroxymetabolites of vitamins D2 and D3. Clin Chem. 2005;51:1683–1690
  36. Vogeser M, Kyriatsoulis A, Huber E, Kolbold U. Candidate reference method for the quantitation of circulating 25-hydroxyvitamin D3 by liquid chromatography tandem-mass spectrometry. Clin Chem. 2004;50:1415–1417
  37. Chen H, McCoy LF, Schleichter RL, Pfeiffer CM. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta. 2008;391:6–12
  38. Singh R, Taylor R, Reddy R, et al. C-3 epimers can account for a significant portion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91:3055–3061
  39. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem. 2006;52:1120–1126
  40. Trang H, Cole D, Rubin L, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854–858
  41. Stenman UH. Immunoassay standardization: is it possible, who is responsible, who is capable?. Clin Chem. 2001;47:815–820
  42. Valdes RJ, Jortani S. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem. 2002;48:405–406
  43. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem. 2008;45:153–159
  44. Glendenning P, Taranto M, Noble JM, et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem. 2006;43:23–30
  45. Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diab Obes. 2008;15:489–494
  46. Ramakkrishnan K, Holick MF. Underestimation of 25-OHvitamin D by Nichols Advantage Assay in patients receiving vitamin D replacement therapy. Clin Chem. 2005;51:1074
  47. Cavalier E, Wallace AM, Knox S, et al. Serum vitamin D measurement may not reflect what you give to your patients. J Bone Miner Res. 2008;23:1864–1865
  48. Lensmeyer GL, Binkley N, Drezner MK. New horizons for assessment of vitamin D status in man. In:  Bilezikian JP editors. Dynamics of bone and cartilage metabolism principles and clinical applications. 2nd ed. San Diego: Academic Press; 2006;p. 513–528
  49. Healy MJR. Outliers in clinical chemistry quality-control schemes. Clin Chem. 1979;25:675–677
  50. Binkley N. Vitamin D: clinical measurement and use. J Musculoskelet Neuronal Interact. 2006;6:338–340
  51. Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92:2130–2135
  52. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr. 2008;88(Suppl):511S–512S
  53. Binkley N, Krueger D, Engelke JA, Drezner MK. What is your patient's vitamin D status? Clinical consideration of variability in a 25(OH)D measurement. J Bone Miner Res. 2008;23(Suppl 1):S351
  54. Rejnmark L, Lauridsen AL, Brot C, et al. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest. 2006;66:227–238
  55. Lester E, Skinner RK, Wills MR. Seasonal variation in serum 25-hydroxyvitamin D in the elderly in Britain. Lancet. 1977;1:979–980
  56. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–716
  57. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501
  58. Vieth R. Vitamin D toxicity, policy and science. J Bone Miner Res. 2007;22(Suppl 2):V64–V68
  59. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr. 1999;69:842–856
  60. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317–322
  61. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab. 2002;87:4952–4956
  62. Binkley N, Drezner MK, Hollis BW. Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem. 2006;52:2124–2125
  63. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28
  64. Binkley N, Krueger D, Lensmeyer GL, et al. Is clinical measurement of 25-hydroxyvitamin D still a problem?. Osteoporos Int. 2009;20(Suppl 2):S202
  65. Tangpricha V, Turner A, Spina C, et al. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004;80:1645–1649
  66. Heaney RP. Nutrition and chronic disease. Mayo Clin Proc. 2006;81:297–299
  67. Lowe H, Binkley N, Blaner WS, et al. Vitamin D toxicity due to a commonly available remedy from the Dominican Republic. J Bone Miner Res. 2008;23(Suppl 1):S288
  68. Pepper KJ, Judd SE, Nanes MS, Tangpricha V. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract. 2009;15:95–103
  69. Przybelski R, Agrawal S, Krueger D, et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int. 2008;19:1621–1628
  70. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351(9105):805–806
  71. Heaney RP, Davies KM, Chen TC, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204–210
  72. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008;88(Suppl):507S–510S

PII: S1094-6950(09)00151-6

doi: 10.1016/j.jocd.2009.06.001

Journal of Clinical Densitometry
Volume 12, Issue 4 , Pages 417-427 , October 2009

Article Tools

* Image Usage & Resolution